IRLAB Therapeutics Dividend
Dividend criteriumcontroles 0/6
IRLAB Therapeutics does not have a record of paying a dividend.
Belangrijke informatie
n/a
Dividendrendement
n/a
Terugkoop Rendement
Totaal aandeelhoudersrendement | n/a |
Toekomstig dividendrendement | n/a |
Dividendgroei | n/a |
Volgende betaaldatum dividend | n/a |
Ex-dividenddatum | n/a |
Dividend per aandeel | n/a |
Uitbetalingsratio | n/a |
Recente dividendupdates
Geen updates
Recent updates
Is IRLAB Therapeutics (STO:IRLAB A) Using Debt Sensibly?
Oct 30IRLAB Therapeutics (STO:IRLAB A) Has Debt But No Earnings; Should You Worry?
Jun 06Here's Why We're Watching IRLAB Therapeutics' (STO:IRLAB A) Cash Burn Situation
Jan 04Here's Why IRLAB Therapeutics (STO:IRLAB A) Must Use Its Cash Wisely
Sep 21We Think IRLAB Therapeutics (STO:IRLAB A) Needs To Drive Business Growth Carefully
Mar 18IRLAB Therapeutics (STO:IRLAB A) Is In A Good Position To Deliver On Growth Plans
Dec 01We Like IRLAB Therapeutics' (STO:IRLAB A) Earnings For More Than Just Statutory Profit
May 19We're Interested To See How IRLAB Therapeutics (STO:IRLAB A) Uses Its Cash Hoard To Grow
Sep 11We're Interested To See How IRLAB Therapeutics (STO:IRLAB A) Uses Its Cash Hoard To Grow
Apr 30What Is The Ownership Structure Like For IRLAB Therapeutics AB (publ) (STO:IRLAB A)?
Mar 19We Think IRLAB Therapeutics (STO:IRLAB A) Can Afford To Drive Business Growth
Jan 25Our View On IRLAB Therapeutics' (STO:IRLAB A) CEO Pay
Dec 21What Is The Ownership Structure Like For IRLAB Therapeutics AB (publ) (STO:IRLAB A)?
Nov 25Stabiliteit en groei van betalingen
Dividenden ophalen
Stabiel dividend: Insufficient data to determine if IRLAB A's dividends per share have been stable in the past.
Groeiend dividend: Insufficient data to determine if IRLAB A's dividend payments have been increasing.
Dividendrendement versus markt
IRLAB Therapeutics Dividendrendement versus markt |
---|
Segment | Dividendrendement |
---|---|
Bedrijf (IRLAB A) | n/a |
Markt onderkant 25% (SE) | 1.6% |
Markt Top 25% (SE) | 4.5% |
Gemiddelde industrie (Pharmaceuticals) | 2.4% |
Analist prognose (IRLAB A) (tot 3 jaar) | n/a |
Opmerkelijk dividend: Unable to evaluate IRLAB A's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
Hoog dividend: Unable to evaluate IRLAB A's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Winstuitkering aan aandeelhouders
Verdiendekking: Insufficient data to calculate IRLAB A's payout ratio to determine if its dividend payments are covered by earnings.
Contante uitbetaling aan aandeelhouders
Kasstroomdekking: Unable to calculate sustainability of dividends as IRLAB A has not reported any payouts.